Lv3
248 积分 2022-08-10 加入
THU0199 ABX464, A NOVEL DRUG IN THE FIELD OF INFLAMMATION, INCREASES MIR-124 AND MODULATES MACROPHAGES AND T-CELL FUNCTIONS
1个月前
已完结
Safety data on 19 vehicles for use in 1 month oral rodent pre‐clinical studies: administration of hydroxypropyl‐ß‐cyclodextrin causes renal toxicity
1个月前
已完结
Targeting the ischemic cascade: Review on approved and investigational stroke therapies
1个月前
已完结
World Stroke Organization: Global Stroke Fact Sheet 2025
2个月前
已完结
脊髓损伤致神经源性肠功能障碍患者肠道干预研究进展
3个月前
已完结
Discovery of the thieno[2,3-d]pyrimidine-2,4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing hormone receptor antagonist
4个月前
已完结
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As
5个月前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
7个月前
已完结
Explore the key targets and mechanism of Danggui Buxue decoction against ulcerative colitis: network pharmacology and experimental validation
7个月前
已完结
Impact of Dextran Sulfate Sodium Load on the Severity of Inflammation in Experimental Colitis
8个月前
已完结
皖公网安备34019202002308
